Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Debt & Borrowing

SMS Pharmaceuticals Debt & Borrowing: ₹50 Cr

SMS Pharmaceuticals has signed a loan agreement lending up to Rs.50 Crore to its 99.99%-owned subsidiary SMS Peptides. The unsecured, arm's-length facility has nil outstanding as on date.

Key figures
Value₹50.00 Cr
Source

NSE filing, NSE: SMSPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

SMS Pharmaceuticals Ltd: key numbers

Share price
₹511.35
Market cap
₹4,533 Cr
Revenue (annual)
₹886.9 Cr
Net profit (annual)
₹102.0 Cr
P/E (TTM)
44.3×Sector 48.7×
Promoter holding
68.07%+0.00% QoQ
FII holding
1.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from SMS Pharmaceuticals Ltd

All →

Other debt & borrowing announcements

All →